COVID-19 outcomes in MS
Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 11, 2020
- Accepted in final form June 12, 2020
- First Published July 9, 2020.
Author Disclosures
- Erica Parrotta, DO,
- Ilya Kister, MD,
- Leigh Charvet, PhD,
- Carrie Sammarco, DNP,
- Valerie Saha, NP,
- Robert Erik Charlson, MD,
- Jonathan Howard, MD,
- Josef Maxwell Gutman, MD,
- Malcolm Gottesman, MD,
- Nada Abou-Fayssal, MD,
- Robyn Wolintz, MD,
- Marshall Keilson, MD,
- Cristina Fernandez-Carbonell, MD,
- Lauren B. Krupp, MD and
- Lana Zhovtis Ryerson, MD
- Erica Parrotta, DO,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ilya Kister, MD,
Biogen Idec MS Franchise Data Generation Advisory Board Genentech Advisory Board
NONE
NONE
NONE
NONE
NONE
NONE
Biogen Idec one-time consulting fee Roche consulting fee
NONE
NONE
NONE
Received research support from Biogen-Idec, Serono, Novartis, Genzyme, Genentech
NONE
NONE
(1) Guthy-Jackson Charitable Foundation (2) National Multiple Sclerosis Society
NONE
NONE
NONE
NONE
NONE
NONE
- Leigh Charvet, PhD,
NONE
NONE
Biogen Idec
NONE
NONE
NONE
NONE
Springer Healthcare Publishing
NONE
NONE
NONE
Has received research funding from Biogen Idec
NIH, U.S. Department of Defense
NONE
National MS Society Stock/Stock Options, Medical Equipment & Materials: Johnson & Johnson
NONE
NONE
NONE
NONE
NONE
NONE
- Carrie Sammarco, DNP,
NONE
NONE
BIOGEN, Genentech, BMS
NONE
NONE
NONE
NONE
NONE
BIOGEN, Genentech, BMS
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Valerie Saha, NP,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Erik Charlson, MD,
NONE
NONE
I have been on speaker's bureau for Biogen. I also have done consulting work for Novartis.
NONE
NONE
NONE
NONE
NONE
I have been on the speakers' bureau for Biogen.
NONE
NONE
I have been site PI for Biogen supported study.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jonathan Howard, MD,
NONE
NONE
NONE
NONE
NONE
Neurology Video Textbook, Demos-Springer Publishing, 2013 Neurology Image-Based Clinical Review, Demos-Springer Publishing, Aug 25, 2016 Howard, J. Cognitive Errors and Diagnostic Mistakes: A Case-Based Guide to Critical Thinking in Medicine. Springer Publishing, 2019.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Expert witness for plaintiff, 2016 Sbrogna & Brunelle, LLP
- Josef Maxwell Gutman, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Malcolm Gottesman, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nada Abou-Fayssal, MD,
NONE
NONE
Speaker honoraria from Novartis
NONE
NONE
NONE
NONE
NONE
Novartis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robyn Wolintz, MD,
NONE
NONE
Biogen Mallinkrodt Sanofi Genzyme
NONE
NONE
NONE
NONE
NONE
Biogen Mallinkrodt Sanofi/Genzyme
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marshall Keilson, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cristina Fernandez-Carbonell, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lauren B. Krupp, MD and
Served on a DSMB for Sanofi
NONE
attended meetings with travel covered by Biogen, Novartis, and Sanofi
NONE
NONE
NONE
NONE
Served as a consultant for pediatric MS studies for Novartis and Biogen
NONE
NONE
NONE
Biogen
National Institutes of Health, Co-Investigator,
NONE
National Multiple Sclerosis Society
NONE
Received licensing fees from pharmaceutical and biomedical companies for use of the fatigue severity scale
NONE
NONE
NONE
NONE
- Lana Zhovtis Ryerson, MD
Biogen
NONE
Biogen
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Biogen
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the NYU Langone Multiple Sclerosis Comprehensive Care Centers (E.P., I.K., L.C., C.S., V.S., R.E.C., J.H., J.M.G., M.G., N.A.-F., R.W., M.K., L.B.K., L.Z.R.), New York, NY; and Cohen's Children Medical Center Northwell Health (C.F.-C.), Lake Success, NY.
- Correspondence
Dr. Zhovtis Ryerson lana.zhovtisryerson{at}nyulangone.org
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North AmericaFrom the COViMS RegistryScott D. Newsome, Anne H. Cross, Robert J. Fox et al.Neurology: Neuroimmunology & Neuroinflammation, August 24, 2021 -
Commentary
COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying TherapyAndrew Wolf, Enrique Alvarez et al.Neurology: Clinical Practice, April 14, 2021 -
Special Editorial
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemicWallace Brownlee, Dennis Bourdette, Simon Broadley et al.Neurology, April 02, 2020 -
Article
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum DisordersSamira Luisa Apostolos-Pereira, Lis Campos Ferreira, Mateus Boaventura et al.Neurology: Neuroimmunology & Neuroinflammation, August 26, 2021